Kymera Therapeutics Announces First Quarter 2022 Financial Results and Provides a Business Update

Go back to Kymera Therapeutics Announces First Quarter 2022 Financial Results and Provides a Business Update
(NASDAQ: KYMR) Delayed: 73.95 -0.18 (0.24%)
Previous Close $74.13    52 Week High
Open $74.73    52 Week Low
Day High $75.34    P/E N/A 
Day Low $73.33    EPS
Volume 453,688